MedPath

SYNERCID

SYNERCID

Discontinued
DIN Number

02241323

Drug Class

Human

Market Date

Jul 5, 2000

Company
HC

monarch pharmaceuticals ireland limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02241323
AIG Number0239201001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01FG02 QUINOPRISTIN AND DALFOPRISTIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:12.28.32
Health Canada Classification

ACTIVE INGREDIENTS (2)

DALFOPRISTINActive
Strength: 350 MG / VIAL
Monograph: DALFOPRISTIN
QUINUPRISTINActive
Strength: 150 MG / VIAL
Monograph: QUINUPRISTIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.